Premenstrual Syndromes—An Approach to Diagnosis and Treatment

References

• Bailey, Bailey, Cohen, LS. Prevalence of mood and anxiety disorders in women who seek treatment for premenstrual syndrome. J Womens Health Gend Based Med 1999; 8:1181.
   PubMedGoogle Scholar
• Steiner, Steiner, Born, Born. Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol 2000; 15 Suppl 3:S5.
   PubMed Web of Science ®Google Scholar
• Amercian Psychiatric Association. Diagnostic and Statistical Manual Edition IV, American Psychiatric Association, Washington, DC 1994, p715.
   Google Scholar
• Halbreich, Halbreich, Endicott, Endicott, Lesser J. The clinical diagnosis and classification of premenstrual changes. Can J Psychiatr 1985; 30:489.
   PubMed Web of Science ®Google Scholar
• Schmidt, Schmidt, Nieman, Nieman, Danaceau< MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998; 338:209.
   PubMed Web of Science ®Google Scholar
• Wardlaw, Wardlaw, Thoron, Thoron, Frantz, AG. Effects of sex steroids on brain beta-endor- phin. Brain Res 1982; 245:327
   Google Scholar
• Giannini, Giannini, Martin, Martin, Turner, CE. Beta-endorphin decline in late luteal phase dysphoric disorder. Int J Psychiatry Med 1990; 20:279.
   PubMed Web of Science ®Google Scholar
• Taylor, Taylor, Matthew, Matthew, Ho, BT, et al. Serotonin levels and platelet uptake during premenstrual tension. Neuropsychobiology 1984; 12:16.
   PubMed Web of Science ®Google Scholar
• Chuong, Chuong, Coulam, Coulam, Koo, PC, et al. Neuropeptide levels in premenstrual syndrome. Fertil Steril 1985; 44:760.
   PubMed Web of Science ®Google Scholar
• Rapkin, Rapkin, Edelmuth, Edelmuth, Chang, LC, et al. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 1987; 70:533.
   PubMed Web of Science ®Google Scholar
• Beck, Beck, Gevirtz, Gevirtz, Mortola, JF. The predictive role of psychosocial stress on symptom severity in premenstrual syndrome. Psychosom Med 1990; 52:536.
   PubMed Web of Science ®Google Scholar
• Fontana, Fontana, Palfai, TG. Psychosocial factors in premenstrual dysphoria: Stressors, appraisal, and coping processes. J Psychosom Res 1994; 38:557.
   PubMed Web of Science ®Google Scholar
• Dimmock, Dimmock, Wyatt, Wyatt, Jones, Jones, O'Brien, PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000; 356:1131.
   PubMed Web of Science ®Google Scholar
• Wyatt, Wyatt, Dimmock, Dimmock, O'Brien, PM. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2002;:CD001396.
   Google Scholar
• Cohen, Cohen, Miner, Miner, Brown, EW, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol 2002; 100:435
   Google Scholar
• Smith, Smith, Reinhart, Reinhart, Ruddock, Ruddock, Schiff, Schiff. Treatment of premenstrual syndrome with alprazolam: Results of a double blind, placebo controlled, randomized crossover clinical trial. Obstet Gynecol 1987; 70:37.
   PubMed Web of Science ®Google Scholar
• Harrison, Harrison, Endicott, Endicott, Nee, Nee. Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch Gen Psychiatry 1990; 47:270
   Google Scholar
• Berger, Berger, Presser, Presser. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study. Obstet Gynecol 1994; 84:379
   Google Scholar
• Yonkers, Yonkers, Brown, Brown, Pearlstein, Pearlstein, Foegh, Foegh. Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder. Obstet Gynecol 2005; 106:492.
   PubMed Web of Science ®Google Scholar
• Pearlstein, Pearlstein, Bachmann, Bachmann, Zacur, Zacur, Yonkers, KA. Treatment of premenstrual dysphoric disorder with a new drospire- none-containing oral contraceptive formulation. Contraception 2005; 72:414.
   PubMed Web of Science ®Google Scholar
• Freeman, Freeman, Sondheimer, Sondheimer, Rickels, Rickels. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997; 33:303.
   PubMed Web of Science ®Google Scholar
• Brown, Brown, Ling, Ling, Andersen, RN, et al. Efficacy of depot leuprolide in premenstrual syndrome: Effect of symptoms severity and type in a controlled trial. Obstet Gynecol 1994; 84:779.
   PubMed Web of Science ®Google Scholar
• Berger, Berger, Presser, Presser. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: a double-blind, placebo-controlled crossover study. Obstet Gynecol 1994; 84:379.
   PubMed Web of Science ®Google Scholar
• Thys-Jacobs, S, S, P, P, D, Tian, Tian Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998; 179:444.
   PubMed Web of Science ®Google Scholar
• Wyatt, Wyatt, Dimmock, Dimmock, Jones, Jones, Shaughn O'Brien PM., Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: Systematic review. BMJ 1999; 318: 1375.
   PubMed Web of Science ®Google Scholar